• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Biomarkers of malignant ascites-a myth or reality.恶性腹水的生物标志物——神话还是现实。
Med J Armed Forces India. 2011 Apr;67(2):108-12. doi: 10.1016/S0377-1237(11)60005-1. Epub 2011 Jul 21.
2
Diagnosing ascitic etiology on a biochemical basis.基于生化指标诊断腹水病因。
Hepatogastroenterology. 1998 Sep-Oct;45(23):1673-7.
3
Usefulness of ascitic fluid cholesterol as a marker for malignant ascites.腹水胆固醇作为恶性腹水标志物的实用性。
Med Sci Monit. 2005 Mar;11(3):CR136-42.
4
Total discrimination of peritoneal malignant ascites from cirrhosis- and hepatocarcinoma-associated ascites by assays of ascitic cholesterol and lactate dehydrogenase.通过检测腹水胆固醇和乳酸脱氢酶对腹膜恶性腹水与肝硬化及肝癌相关性腹水进行全面鉴别。
Clin Chem. 1994 Mar;40(3):478-83.
5
Diagnosing ascites: value of ascitic fluid total protein, albumin, cholesterol, their ratios, serum-ascites albumin and cholesterol gradient.腹水的诊断:腹水总蛋白、白蛋白、胆固醇及其比值、血清-腹水白蛋白梯度和血清-腹水胆固醇梯度的价值
J Gastroenterol Hepatol. 1995 May-Jun;10(3):295-9. doi: 10.1111/j.1440-1746.1995.tb01096.x.
6
(1)H NMR spectroscopy of ascitic fluid: discrimination between malignant and benign ascites and comparison of the results with conventional methods.腹水的¹H核磁共振波谱分析:鉴别恶性腹水与良性腹水并将结果与传统方法进行比较。
NMR Biomed. 2008 Jul;21(6):606-14. doi: 10.1002/nbm.1232.
7
[Concentration of lipids in ascitic fluid and the concentration gradient of albumin in blood and ascites: diagnostic significance].[腹水脂质浓度及血液与腹水白蛋白浓度梯度:诊断意义]
Ann Gastroenterol Hepatol (Paris). 1989 Nov;25(6):251-6.
8
[Differentiation of malignant and non-malignant origin of ascites by determination of levels of cholesterol and lactate dehydrogenase in ascitic fluid is not absolute].
Vnitr Lek. 2000 Jan;46(1):5-11.
9
Evaluation of fibronectin as a marker of malignant ascites.评估纤连蛋白作为恶性腹水标志物的作用。
J Gastroenterol Hepatol. 1992 Mar-Apr;7(2):161-4. doi: 10.1111/j.1440-1746.1992.tb00955.x.
10
Differential diagnosis of ascites: etiologies, ascitic fluid analysis, diagnostic algorithm.腹水的鉴别诊断:病因、腹水分析、诊断算法
Clin Chem Lab Med. 2023 Dec 20;62(7):1266-1276. doi: 10.1515/cclm-2023-1112. Print 2024 Jun 25.

引用本文的文献

1
Peritoneal lymphomatosis as a rare entity of post-transplant lymphoproliferative disorder after kidney transplantation: a case report.腹膜淋巴瘤作为肾移植后移植后淋巴增殖性疾病的一种罕见表现:一例报告
CEN Case Rep. 2025 Feb 19. doi: 10.1007/s13730-025-00976-5.
2
Development and validation a simple model for identify malignant ascites.开发并验证一种简单的模型用于识别恶性腹水。
Int J Med Sci. 2021 Mar 3;18(9):1966-1974. doi: 10.7150/ijms.53743. eCollection 2021.
3
Biomarkers of malignant ascites-a myth or reality.恶性腹水的生物标志物——神话还是现实。
Med J Armed Forces India. 2011 Oct;67(4):398. doi: 10.1016/S0377-1237(11)60100-7. Epub 2011 Oct 22.

本文引用的文献

1
Value of ascitic fluid ferritin in the differential diagnosis of malignant ascites.腹水铁蛋白在恶性腹水鉴别诊断中的价值
Anticancer Res. 1993 Nov-Dec;13(6B):2441-5.
2
Total discrimination of peritoneal malignant ascites from cirrhosis- and hepatocarcinoma-associated ascites by assays of ascitic cholesterol and lactate dehydrogenase.通过检测腹水胆固醇和乳酸脱氢酶对腹膜恶性腹水与肝硬化及肝癌相关性腹水进行全面鉴别。
Clin Chem. 1994 Mar;40(3):478-83.
3
Malignant ascites. Clinical and experimental observations.恶性腹水。临床与实验观察。
Ann Surg. 1986 Jun;203(6):644-51. doi: 10.1097/00000658-198606000-00009.
4
The cytologic diagnosis of malignant neoplasms in pleural and peritoneal effusions.胸膜和腹腔积液中恶性肿瘤的细胞学诊断
Acta Cytol. 1987 Mar-Apr;31(2):85-97.
5
Diagnostic value of ascitic fluid cholesterol levels in the prediction of malignancy.腹水胆固醇水平在预测恶性肿瘤中的诊断价值。
Scand J Gastroenterol. 1988 Nov;23(9):1085-8. doi: 10.3109/00365528809090173.
6
Diagnosis of malignant ascites. Comparison of ascitic fibronectin, cholesterol, and serum-ascites albumin difference.恶性腹水的诊断。腹水纤维连接蛋白、胆固醇及血清-腹水白蛋白梯度的比较。
Dig Dis Sci. 1988 Jul;33(7):833-8. doi: 10.1007/BF01550972.
7
Ascitic fluid concentrations of fibronectin and cholesterol: comparison of differential diagnostic value with the conventional protein determination.腹水纤维连接蛋白和胆固醇浓度:与传统蛋白质测定的鉴别诊断价值比较
Liver. 1990 Jun;10(3):152-7. doi: 10.1111/j.1600-0676.1990.tb00451.x.
8
Ascitic fluid analysis for the differentiation of malignancy-related and nonmalignant ascites. Proposal of a diagnostic sequence.
Cancer. 1991 Oct 15;68(8):1808-14. doi: 10.1002/1097-0142(19911015)68:8<1808::aid-cncr2820680827>3.0.co;2-6.
9
Fibronectin, cholesterol and triglycerides ascitic fluid concentration in the prediction of malignancy.
Ital J Gastroenterol. 1991 May;23(4):179-86.
10
Diagnostic value of ascitic fluid lactic dehydrogenase, protein, and WBC levels.腹水乳酸脱氢酶、蛋白质及白细胞水平的诊断价值。
Arch Intern Med. 1978 Jul;138(7):1103-5.

恶性腹水的生物标志物——神话还是现实。

Biomarkers of malignant ascites-a myth or reality.

作者信息

Banerjee Mithu, Singh Rajeshwar, Arora M M, Srinivas V, Basannar D, Patrikar Seema

机构信息

Associate Professor, Dept. of Biochemistry, AFMC, Pune-40.

Classified Specialist, Medicine & Oncology, CH (EC) Kolkata.

出版信息

Med J Armed Forces India. 2011 Apr;67(2):108-12. doi: 10.1016/S0377-1237(11)60005-1. Epub 2011 Jul 21.

DOI:10.1016/S0377-1237(11)60005-1
PMID:27365781
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4920757/
Abstract

BACKGROUND

Ascitic fluid aspirate cytology, although reasonably specific is not a good screening tool for malignant ascites due to poor sensitivity. Simple test(s) on ascitic fluid or serum which can help differentiate between benign and malignant causes of ascites will be a boon. Ascitic fluid lactate dehydrogenase, cholesterol, and ferritin are the candidate markers evaluated in this study.

METHODS

Ascitic fluid cytology was done on 30 patients of malignant ascites. The modalities used for diagnosing malignant ascites were positive peritoneal biopsy or CT scan evidence of hepatic metastases. Ascitic fluid biochemistry was done in all these 30 patients as well as 30 cases of non-malignant ascites. The parameters analysed were cholesterol, lactate dehydrogenase, and ferritin. The biochemical parameters were estimated in serum as well.

RESULTS

Cytology had a sensitivity of 40% for the diagnosis of malignant ascites. Ascitic fluid cholesterol, lactate dehydrogenase, and ferritin had sensitivities of 70%, 74%, and 100%, respectively. Serum cholesterol, lactate dehydrogenase, and ferritin had sensitivities of 57%, and 91%, respectively.

CONCLUSION

Hence, these biochemical markers in ascitic fluid as well as serum can be good screening tools for the diagnosis of malignant ascites.

摘要

背景

腹水抽吸细胞学检查虽然具有一定的特异性,但由于敏感性较差,并非恶性腹水的良好筛查工具。能够有助于区分腹水良性和恶性病因的腹水或血清简单检测将是一大福音。本研究评估了腹水乳酸脱氢酶、胆固醇和铁蛋白作为候选标志物。

方法

对30例恶性腹水患者进行了腹水细胞学检查。用于诊断恶性腹水的方式为阳性腹膜活检或肝脏转移的CT扫描证据。对这30例患者以及30例非恶性腹水患者均进行了腹水生化检查。分析的参数为胆固醇、乳酸脱氢酶和铁蛋白。同时也对血清中的生化参数进行了测定。

结果

细胞学诊断恶性腹水的敏感性为40%。腹水胆固醇、乳酸脱氢酶和铁蛋白的敏感性分别为70%、74%和100%。血清胆固醇、乳酸脱氢酶和铁蛋白的敏感性分别为57%和91%。

结论

因此,腹水以及血清中的这些生化标志物可作为诊断恶性腹水的良好筛查工具。